English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Figure 1. Changes in the scores of the clinical activity index (CAI) and the plasma levels of macrophage migration inhibitory factor (MIF) in the patients treated with GMA. The statistical significance of the diferences between means were determined by the Wilcoxon signed-rank test. (a) Changes in the scores of CAI before the first session of the granulocyte and monocyte apheresis (GMA) therapy and after the final session of GMA therapy. Before: before the first session of GMA, After: after the final session of GMA. (b) Changes in the plasma MIF levels in preand postGMA therapy at the first session. Pre: pre-GMA, Post: post-GMA. Samples from 6 patients were obtained during the first GMA procedure. (b) (a) □ SHORT COMMUNICATION □

internal medicine

Changes in the Plasma Level of Macrophage Migration Inhibitory Factor in Ulcerative Colitis Patients Treated with Selective Granulocyte and Monocyte Apheresis